No abstract available
MeSH terms
-
Angiogenesis Inhibitors / therapeutic use*
-
Complement C3 / antagonists & inhibitors
-
Complement Inactivating Agents / therapeutic use
-
Geographic Atrophy / drug therapy*
-
Humans
-
Immunoglobulin Fab Fragments / therapeutic use
-
Vascular Endothelial Growth Factor A / antagonists & inhibitors
-
Wet Macular Degeneration / drug therapy*
Substances
-
Angiogenesis Inhibitors
-
Complement C3
-
Complement Inactivating Agents
-
Immunoglobulin Fab Fragments
-
VEGFA protein, human
-
Vascular Endothelial Growth Factor A
-
lampalizumab